A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome.
A double-blind, randomized, placebo controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome.